Achillion Pharmaceuticals Inc
ACHN:NASDAQ
| Last | Change / % Change | Dividend Yield | Volume | Avg Volume (10 day) |
| 7.77 | 0.21 2.78% | 0.00% | 823,358 | 675.6K |
Market data is delayed by at least 20 minutes.
5/18/2013 4:32 AM ET
| Market Comparison | P/E (TTM) | P/E (Forward 12 Months) | PEG | 1 Year EPS Growth Rate | 5 Year EPS Growth Rate |
| ACHN Achillion Pharmaceuticals Inc | -- | -11.7 | -- | 7.40% | -- |
| Major Drugs Industry | 20.9 | 24.1 | 4.7 | -5.02% | 2.42% |
| Healthcare Sector | 24.9 | 17.8 | 4.1 | -48.30% | 6.80% |
| S&P; 500 | 18.1 | 18.9 | 3.6 | -3.64% | 6.28% |
Earnings Summary
On 5/7/2013, ACHN reported 1 quarter 2013 losses of $0.14 per share. This result beat the $0.16 consensus loss of the 11 analysts covering the company and missed last year's 1 quarter results by 7.69%.
The next earnings announcement is expected on 08/05/2013.Insufficient price earnings data.